No correlation between CSF tau protein phosphorylated at threonine 181 with neocortical neurofibrillary pathology in Alzheimer's disease [2]

Brain

Volumn 130, Issue 10, 2007, Pages

  Buerger, Katharina ^a   Alafuzoff, Irina ^b   Ewers, Michael ^a,c   Pirttilä, Tuula ^b   Zinkowski, Raymond ^d   Hampel, Harald ^a,c  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

^c ADELAIDE AND MEATH HOSPITAL   (Ireland)

^d Applied NeuroSolutions Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MARKER; TAU PROTEIN; THREONINE;

ALZHEIMER DISEASE; BOOTSTRAPPING; BRAIN TISSUE; CEREBROSPINAL FLUID; CORRELATION ANALYSIS; DISEASE ASSOCIATION; HUMAN; IMMUNOHISTOCHEMISTRY; LETTER; MEDICAL LITERATURE; NEURITE; NEUROFIBRILLARY TANGLE; NEUROFILAMENT; NEUROPIL THREAD; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; STATISTICAL ANALYSIS; TISSUE HOMOGENATE;

EID: 34848881612     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awm140     Document Type: Letter

References (4)

1. Braak H, Braak E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathol 1991; 82: 239-59.
2. Buerger K, Ewers M, Pirttilä T, Zinkowski R, Alafuzoff I, Teipel SJ, et al. CSF phosphorylated tau protein correlates with neocortical neurofibrillary pathology in Alzheimer's disease. Brain 2006; 129: 3035-41.
3. Engelborghs S, Sleegers K, Cras P, Brouwers N, Serneels S, de Leenheir E, et al. No association of CSF biomarkers with Apoe ε4, plaque and tangle burden in definite Alzheimer's disease. Brain, 2007; 130: 2320-2326.
4. Hampel H, Buerger K, Zinkowski R, Teipel SJ, Goernitz A, Andreasen N, et al. Measurement of phosphorylated tau epitopes in the differential diagnosis of Alzheimer disease: a comparative cerebrospinal fluid study. Arch Gen Psychiatry 2004; 61: 95-102.